普萘洛尔联合其他治疗措施治疗婴幼儿血管瘤有效率的网状Meta分析

目的:采用网状Meta分析方法,将普萘洛尔联合其他治疗与各对照治疗措施进行对比。方法:以“普萘洛尔”,“血管瘤”为关键词检索CNKI、VIP、万方数据;以“propranolol”“hemangioma”为关键词检索Cochrane Library、Embase、pubmed。检索期限为建库至2019年6月1日。采用STATA14.0软件Network程序包进行数据分析。结果:共纳入18篇文献,涉及8项治疗措施,共纳入1469例血管瘤患者。网状Meta分析结果显示:4种联合治疗方式与单纯口服普萘洛尔相比疗效均优于单纯口服普萘洛尔治疗。普萘洛尔联合注射平阳霉素、普萘洛尔联合外用噻吗洛尔、普萘洛尔联合敷贴器的有效率均优于对应的注射平阳霉素、外用噻吗洛尔及敷贴器。各治疗措施的有效性排序为:普萘洛尔联合敷贴器>普萘洛尔联合外用噻吗洛尔>普萘洛尔联合口服糖皮质激素>普萘洛尔联合注射平阳霉素>敷贴器照射>外用噻吗洛尔>口服普萘洛尔>注射平阳霉素。结论:对于婴幼儿血管瘤的治疗,普萘洛尔联合治疗措施疗效均优于单纯的口服普萘洛尔治疗,其中普萘洛尔联合敷贴器的疗效最佳。     

Modulating effects of posttraining epinephrine on memory: Involvement of the amygdala noradrenergic system

These experiments examined the effects, on retention, of posttraining intra-amygdala administration of norepinephrine (NE), and propranolol. Rats were trained on a one-trial step-through inhibitory avoidance task and tested for retention 24 h later. Injections were administered bilaterally (1.0 microliter/injection) through chronically-implanted cannulae. Low doses of NE (0.1 or 0.3 microgram) administered shortly after training enhanced retention while higher doses (1.0 or 5.0 micrograms) were ineffective. Retention was not affected by NE administered 3 h after training. The effect of intra-amygdala NE on retention is blocked by simultaneous administration of propranolol (0.2 microgram). This finding suggests that the memory-enhancing effect of NE may be mediated by beta-receptors. Posttraining intra-amygdala NE also attenuated the retention deficit produced by adrenal demedullation. Further, intra-amygdala injections of propranolol (0.2 microgram) blocked the enhancing effect, on retention, of posttraining s.c. injections of epinephrine. These findings suggest that activation of noradrenergic receptors in the amygdala may be involved in memory processing and may play a role in the memory-modulating effect of peripheral epinephrine.     

电刺激膈神经中枢端引起降压反应的外周机理

电刺激麻醉家兔膈神经中枢端呆引起动脉血压下降，此降压反应不能被剪断双侧迷走神经所阻断；但可被静脉注射心得１．０ｍｇ／ｋｇ部分阻断；也可被静注射酚妥拉明２．０ｍｇ／ｋｇ部分阻断，去除缓冲神经后其降压效应更为明显。     

可乐定和普萘洛尔对实验性肾性高血压糖尿病性心肌病的影响

可乐定和普萘洛尔治疗肾性高血压糖尿病性心肌病大鼠的心肌组织学改变,表明可乐定和普萘洛尔均使大鼠血压下降,体重恢复,心肌灶性坏死和纤维化减少。普萘洛尔组血管周围纤维化好转比可乐定组明显,可乐定组心肌纤维化改善较普萘洛尔组明显。其机制可能与抗交感紧张和减少儿茶酚胺对心肌损伤有关。     

刺激颈迷走神经引起的心动过速及其对心脏功能的影响

刺激犬的颈迷走神经外周端时可引起心动过缓,而对心脏的抑制作用则逐渐减弱,表现为心率逐渐恢复(但比对照慢)。刺激后DBP立即下降,而SBP系逐渐下降,且下降程度没有DBP大。在刺激时及停止后均出现ES,其分别占刺激次数的47％和53％。在刺激停止后出现PVT(平均加速24.5次/min),PVT期间R波和BP波数不等,SV和BP轻度降低。LVET缩短和PEP/LVET比值升高,出现ES时,SV和BP较ES前显著降低。反映PVT时心脏功能降低。PVT的要理不太清楚,本研究表明反射性迷走撤退在PVT中不起作用。Q-T/Q-S_2比值增大是CA释放的间接证据。心得安可减弱PVT,阿托品可增强PVT,说明PVT由迷走静经释放CA所致。     

甲基黄酮醇胺盐酸盐对异丙肾上腺素正性频率作用的影响

本文比较了甲基黄酮醇胺盐酸盐(MFOA)、普萘洛尔(Pro)、维拉帕米(Ver)对异丙肾上腺素(Iso)所致兔离体右心房正性频率作用的影响。Pro使Iso累积浓度反应曲线平行右移,不抑制最大反应,属于典型的竞争性抑制剂,其pA2=8.43;MFOA和Ver使Iso量效曲线向下右移,抑制最大反应,为非竞争性拮抗。MFOA(2×10~(-5)M)和Ver(2×10~(-7)M)分别使最大反应下降19.28％和48.57％,其pD'2值分别为4.07±0.14、6.68±0.15。结果表明MFOA的作用不同于Pro,和Ver相似。     

An Electrically Modulated Drug Delivery Device. III. Factors Affecting Drug Stability During Electrophoresis

A number of factors affecting the stability of propranolol HC1 during electrophoretic control were investigated. It was found that significant degradation of propranolol HC1 and hydrolysis of water occurred when a current of 15 mA was used with platinized electrodes. This degradation was thought to be due to decomposition of propranolol HC1 at the electrodes. Degradation could be significantly reduced by using uncoated platinum electrodes and currents in the range of 0 to 2.5 mA, while still allowing control of drug delivery rates. Electrode reaction processes were found at high ionic strengths and high drug concentrations but were not thought to be associated with drug decomposition.     

虎杖结晶4号对大鼠工作心脏功能的影响

虎杖4号结晶(简称PD)对正常大鼠离体工作心脏有明显的正性肌力作用,但不加快心率,PD能对抗普萘洛尔的负性肌力作用。PD还能拮抗苯巴比妥钠所致心力衰竭。     

普洛奈尔对立位-速尿激发RAA系统分泌的观察

报道6名正常健康人普洛奈尔对立位-速尿激发试验致血管紧张素-I(AT-I)、醛固酮(Aldo)分泌的观察。结果显示正常人AT-I、Aldo经立位-速尿激发后反应明显(P<0.01～0.001)。加用普洛奈尔后,AT-I除120分较基础值有显著升高外(P<0.05),余各时相均无统计学意义。说明部分地抑制了AT-I对立位-速尿的激发反应;Aldo各时相值与基础值相比均未升高,却在120分与135分两时相抑制日明显低于激发日,普洛奈尔完全抑制Aldo对激发试验的正常反应。结论提示β-肾上腺素能参与肾素-血(?)紧张素-醛固酮(RAA)轴的调节作用。